OPADE Project Annual Meeting in Salerno

Jun 27, 2024.

The OPADE Project (Optimise and predict antidepressant efficacy for patients suffering from major depressive disorders using multi-omics analysis and AI-predictive tool) held its annual meeting at the EBRIS headquarters in Salerno on 19-20 June. This project, which focuses on the microbiota-brain axis and its role in mental health, brought together experts in areas as diverse as clinical research, Major Depressive Disorder (MDD), data science, biotechnology, omics, microbiome, and precision biomarker development, among others.

During the meeting, researchers presented the significant advances being made in the project. These advances could revolutionise the diagnosis and treatment of depression, providing healthcare professionals with more accurate decision-making tools. This multidisciplinary approach will provide a better understanding of the complex interaction between the gut microbiota and the brain, opening up new avenues for tackling MDD.

The research team also discussed future collaborations, dissemination strategies and upcoming milestones in the project. The meeting concluded with a renewed commitment to move towards a better understanding of mental health and improved quality of life for those suffering from depressive disorders.

Recruitment centres are currently enrolling patients, if you are interested in participating please write to: info@opade-project.eu

For more information about the project, please visit the OPADE website or follow us on social media.